GLP-1 patients commonly develop vitamin D insufficiency due to reduced food intake and fat malabsorption. Is supplementation safe? Pharmacist-reviewed.
Ozempic (semaglutide inj.)Wegovy (semaglutide inj.)Rybelsus (oral semaglutide)+Vitamin D
🔵
Monitor
Semaglutide + Vitamin D
No direct pharmacokinetic interaction. However, semaglutide patients have elevated risk of vitamin D insufficiency due to reduced caloric intake and fat malabsorption. Monitoring vitamin D levels and appropriate supplementation is generally recommended.
What This Means
In Plain Language
Semaglutide and vitamin D do not interact at a pharmacokinetic level — they do not compete for metabolic pathways or affect each other's absorption. The reason this interaction warrants monitoring is different: GLP-1 medications significantly reduce appetite and food intake, which can reduce dietary vitamin D. Additionally, semaglutide's effect on gastric emptying may affect the absorption of fat-soluble vitamins like vitamin D. Regular monitoring of 25-hydroxyvitamin D levels is prudent for long-term semaglutide users.
Clinical Considerations
Key Risks & Factors
Increased insufficiency risk: Reduced caloric intake on semaglutide decreases dietary vitamin D. GLP-1 effects on fat absorption may further reduce vitamin D bioavailability.
No pharmacokinetic interaction: Vitamin D supplementation does not alter semaglutide's efficacy or blood levels. This is a monitoring concern, not a contraindication.
Timing for Rybelsus users: Rybelsus must be taken on an empty stomach. Vitamin D supplements (fat-soluble) are best absorbed with a meal containing fat — take vitamin D with your largest meal, well separated from your morning Rybelsus dose.
Hypercalcemia risk at very high doses: Vitamin D toxicity (typically requiring doses above 4,000 IU/day long-term) can cause hypercalcemia. Standard supplemental doses (1,000–2,000 IU/day) are safe for most adults and do not present this risk.
Conservative Safety Assessment
Vitamin D supplementation at standard doses is safe alongside semaglutide. The primary clinical concern is ensuring adequate vitamin D status during long-term GLP-1 therapy, as reduced dietary intake and potential fat absorption changes may lead to insufficiency. This 'Monitor' rating reflects a monitoring recommendation, not a safety warning. Reviewed and audited by Sanford A. Orloff, RPh (ret).
Enter all your medications, supplements, and lifestyle substances to see a complete pharmacist-reviewed interaction report — free, no account required.
Pharmacist-reviewed · FDA & NIH sources only · Always free
👨⚕️
Sanford A. Orloff, RPh (ret)
Registered Pharmacist · 40+ Years Clinical Experience · NPI 1518289974
Every interaction profile on InteractSafe is reviewed for editorial accuracy by a retired pharmacist with over 40 years of clinical experience in medication therapy management, patient counseling, and pharmaceutical care.
Yes — vitamin D supplementation is generally safe alongside semaglutide. There is no direct pharmacokinetic interaction. In fact, vitamin D monitoring and appropriate supplementation is often recommended for long-term GLP-1 patients due to reduced dietary intake. Discuss optimal dosing with your physician based on your 25-OH vitamin D lab results.
Semaglutide does not directly cause vitamin D deficiency, but the combination of significantly reduced food intake and potential changes in fat absorption on GLP-1 therapy can contribute to vitamin D insufficiency over time. Patients on long-term semaglutide therapy should have their vitamin D levels checked periodically.
Rybelsus (oral semaglutide) requires an empty stomach and 30 minutes before food, drink, or other medications. Vitamin D is fat-soluble and is best absorbed with a meal containing fat. Take your Rybelsus in the morning as directed, and take your vitamin D supplement with lunch or dinner to maximize both absorption and compliance.
This profile is for educational purposes only. Reviewed for editorial accuracy by Sanford A. Orloff, RPh (ret).
It is NOT medical advice and does not replace consultation with a licensed physician or pharmacist.
Never change your medication routine based on this information alone.
Read Full Safety Terms →